Jan. 17, 2011 (Marketwire) --
SUGAR LAND, TX -- (Marketwire) -- 01/17/11 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Now that the books have closed on 2010, an analysis by Industrial Info's Pharmaceutical Tracker - Online Database of capital and maintenance (MRO) projects reveals that more than $9 billion worth of projects were launched last year. The investment was divided among 529 North American projects, resulting in an average project total investment value (TIV) of a little more than $16 million. Significant projects by Talecris Biotherapeutics (NASDAQ:TCLR), GlaxoSmithKline plc (NYSE:GSK), Teva (NASDAQ:TEVA) and McKesson Corporation (NYSE:MCK) began during the year.
For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showNews.jsp?newsitemID=172029, or browse other breaking industrial news stories at www.industrialinfo.com.
Industrial Info Resources (IIR) is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. IIR's quality-assurance philosophy, the Living Forward Reporting Principle?, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. For more information send inquiries to pharmabiogroup@industrialinfo.com or visit us at www.industrialinfo.com.
Follow us on: Facebook - Twitter - LinkedIn - Vimeo
Add to Digg Bookmark with del.icio.us Add to Newsvine